Track topics on Twitter Track topics that are important to you
OrbiMed is a preeminent asset management firm focused on the global health sciences industry, with over $5 billion in assets under management across a family of venture capital funds, hedge funds and other investment vehicles. OrbiMed's investment advisory activities were founded in 1989 by Samuel D. Isaly with a vision to invest across the spectrum of healthcare companies: from small privately-held firms to large multinational companies.
OrbiMed's investment team includes over 20 experienced professionals with backgrounds in science, medicine, finance and law. Our professionals work together in a collaborative, team-oriented approach. OrbiMed seeks to be the capital provider of choice for life sciences companies pursuing growth and new opportunities. Where appropriate, particularly within its venture capital activities, OrbiMed supports its invested companies in achieving strategic, financial and operational objectives via participation at the Board of Directors level. OrbiMed professionals currently serve on the Board of Directors of many different life sciences companies.
767 Third Avenue30th Floor
United States of America
Phone: (212) 739-6400
OrbiMed, a global healthcare investor, closed its third Asia private equity fund with $551 million in capital commitments, about $100 million more than the target listed in its initial filing six mont...
How OrbiMed plans to deploy its $551 million Asia fund. Plus: Verastem’s duvelisib bounce; Wellington Partners’ poster child; and Entasis’ antibiotic engine.
Natera Inc. (genetic testing for reproductive health) entered into a $100mm debt facility with existing investor OrbiMed Advisors. The company immediately drew down $75mm, and has until the end of 201...
Life Sciences Jobs ...
Orbimed fund senior managing partner Nissim Darvish: TASE listing detracts from a company's value.
A round of equity financing led by the KCK Group and OrbiMed Advisors brought in $74 million for Mountain View, Calif.-based -More-
OrbiMed is the largest investment firm dedicated exclusively to the life sciences sector, with over $5 billion in assets under management. OrbiMed invests across the entire spectr...
OrbiMed is a preeminent asset management firm focused on the global health sciences industry, with over $5 billion in assets under management across a family of venture capital funds, hedge funds and ...
The Silverstein Foundation is a 501(c)(3) non-profit organization founded in 2017 focused on investing in cutting edge research with the goal of discovering new therapies for the ...
Founded in 2010, cCAM is a biopharmaceutical company focused on the discovery and development of novel immunotherapies to treat cancer. Its lead product, CM-24, is a Phase 1 ready...
Relypsa, Inc. is a clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascula...
We have published hundreds of OrbiMed news stories on BioPortfolio along with dozens of OrbiMed Clinical Trials and PubMed Articles about OrbiMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OrbiMed Companies in our database. You can also find out about relevant OrbiMed Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...